Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Vascular risk factors for COVID-19 ARDS: endothelium, contact-kinin system. | Front Med (Lausanne) | 2023 | 37448794 | PubTator, text mining | PubMed |
| The host transcriptome change involved in the inhibitory effect of exogenous interferon-γ on Getah virus replication. | Front Microbiol | 2023 | 37448574 | PubTator, text mining | PubMed |
| Beyond the Complement Cascade: Insights into Systemic Immunosenescence and Inflammaging in Age-Related Macular Degeneration and Current Barriers to Treatment. | Cells | 2023 | 37443742 | PubTator, text mining | PubMed |
| Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer. | Front Immunol | 2023 | 37435088 | PubTator, text mining | PubMed |
| Glc7/PP1 dephosphorylates histone H3T11 to regulate autophagy and telomere silencing in response to nutrient availability. | Cell Discov | 2023 | 37433812 | PubTator, text mining | PubMed |
| Citrullination of C1-inhibitor as a mechanism of impaired complement regulation in rheumatoid arthritis. | Front Immunol | 2023 | 37426666 | PubTator, text mining | PubMed |
| Serum RGC-32 in children with systemic lupus erythematosus. | Sci Rep | 2023 | 37422503 | PubTator, text mining | PubMed |
| Complement is activated by elevated IgG3 hexameric platforms and deposits C4b onto distinct antibody domains. | Nat Commun | 2023 | 37419978 | PubTator, text mining | PubMed |
| [Novel anti-complement therapeutics for hemolytic anemia]. | Rinsho Ketsueki | 2023 | 37407469 | PubTator, text mining | PubMed |
| Differentiating between activation via the lectin or the classical complement pathway in patients with systemic lupus erythematosus. | Clin Exp Immunol | 2023 | 37407023 | PubTator, text mining | PubMed |
| Brain and immune system-derived extracellular vesicles mediate regulation of complement system, extracellular matrix remodeling, brain repair and antigen tolerance in Multiple sclerosis. | Brain Behav Immun | 2023 | 37406976 | PubTator, text mining | PubMed |
| Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas. | Biomark Res | 2023 | 37403120 | PubTator, text mining | PubMed |
| A likely association between low mannan-binding lectin level and brain fog onset in long COVID patients. | Front Immunol | 2023 | 37398656 | PubTator, text mining | PubMed |
| Management of hereditary angioedema in resource-constrained settings: A consensus statement from Indian subcontinent. | Asia Pac Allergy | 2023 | 37388810 | PubTator, text mining | PubMed |
| The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma. | BMC Cancer | 2023 | 37386391 | PubTator, text mining | PubMed |
| Structural Model for Factor X Inhibition of IgM and Complement-Mediated Neutralization of Adenovirus. | Viruses | 2023 | 37376642 | PubTator, text mining | PubMed |
| Pathophysiology of Rejection in Kidney Transplantation. | J Clin Med | 2023 | 37373823 | PubTator, text mining | PubMed |
| The axis of complement C1 and nucleolus in antinuclear autoimmunity. | Front Immunol | 2023 | 37359557 | PubTator, text mining | PubMed |
| Complement system in Anti-CD20 mAb therapy for cancer: A mini-review. | Int J Immunopathol Pharmacol | 2023 | 37357623 | PubTator, text mining | PubMed |
| Inhibition of cleavage of human complement component C5 and the R885H C5 variant by two distinct high affinity anti-C5 nanobodies. | J Biol Chem | 2023 | 37356719 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=16